LEADER 01351nam  2200361   450 
001 9910716792403321
005 20210803130806.0
035   $a(CKB)5470000002524248
035   $a(OCoLC)1262663063
035   $a(EXLCZ)995470000002524248
100   $a20210803d2019      ua             0
101 0 $aeng
135   $aurbn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aRecent reported medical events involving the administration of yttrium-90 microspheres for therapeutic medical procedures
210  1$aWashington, DC :$cUnited States Nuclear Regulatory Commission, Office of Nuclear Material Safety and Safeguards,$d2019.
215   $a1 online resource (4 pages)
225 1 $aNRC information notice ;$v2019-12
300   $a"December 31, 2019."
300   $a"ML19262G231."
606   $aNuclear medicine$xAccidents
606   $aYttrium$xIsotopes
615  0$aNuclear medicine$xAccidents.
615  0$aYttrium$xIsotopes.
712 02$aU.S. Nuclear Regulatory Commission.$bOffice of Nuclear Material Safety and Safeguards,
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910716792403321
996   $aRecent reported medical events involving the administration of yttrium-90 microspheres for therapeutic medical procedures$93316013
997   $aUNINA